Literature DB >> 25613459

Nanoparticles in vaccine delivery.

Aliasger K Salem1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25613459      PMCID： PMC4365085          DOI： 10.1208/s12248-015-9720-1

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  20 in total

1.  Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.

Authors:  Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

2.  Biodegradable particles as vaccine delivery systems: size matters.

Authors:  Vijaya B Joshi; Sean M Geary; Aliasger K Salem
Journal:  AAPS J       Date:  2012-10-10       Impact factor: 4.009

3.  Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine.

Authors:  Senthil Murugappan; Harshad P Patil; Henderik W Frijlink; Anke Huckriede; Wouter L J Hinrichs
Journal:  AAPS J       Date:  2014-01-31       Impact factor: 4.009

4.  Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.

Authors:  Vijaya B Joshi; Sean M Geary; Brenda R Carrillo-Conde; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2012-11-12       Impact factor: 8.947

Review 5.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

6.  A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles.

Authors:  Xue-Qing Zhang; Christopher E Dahle; George J Weiner; Aliasger K Salem
Journal:  J Pharm Sci       Date:  2007-12       Impact factor: 3.534

7.  Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles.

Authors:  Xue-Qing Zhang; Christopher E Dahle; Nicki K Baman; Nathan Rich; George J Weiner; Aliasger K Salem
Journal:  J Immunother       Date:  2007 Jul-Aug       Impact factor: 4.456

Review 8.  Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.

Authors:  Vijaya B Joshi; Sean M Geary; Aliasger K Salem
Journal:  Hum Vaccin Immunother       Date:  2013-08-26       Impact factor: 3.452

Review 9.  Nanoparticle delivery systems in cancer vaccines.

Authors:  Yogita Krishnamachari; Sean M Geary; Caitlin D Lemke; Aliasger K Salem
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.580

Review 10.  Applying biodegradable particles to enhance cancer vaccine efficacy.

Authors:  Kawther K Ahmed; Sean M Geary; Aliasger K Salem
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505
View more
  4 in total

1.  Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Authors:  Lázaro Moreira Marques Neto; Nicholas Zufelato; Ailton Antônio de Sousa-Júnior; Monalisa Martins Trentini; Adeliane Castro da Costa; Andris Figueiroa Bakuzis; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

Review 2.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

Review 3.  Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement.

Authors:  Atin Khalaj-Hedayati; Caroline Lin Lin Chua; Peter Smooker; Khai Wooi Lee
Journal:  Influenza Other Respir Viruses       Date:  2019-11-27       Impact factor: 4.380

Review 4.  Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells.

Authors:  Fei-Long Qi; Mei-Fang Wang; Bo-Zhao Li; Ze-Fang Lu; Guang-Jun Nie; Su-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2020-05-28       Impact factor: 6.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.